Articles From: Lionsgate Increases Quarterly Cash Dividend From $0.05 To $0.07 Per Common Share to LiqTech International, Inc. Announces $350,000 First Order Received By The Newly Combined LiqTech/Provital Company


VANCOUVER and SANTA MONICA, Calif.
Sign-up for Lionsgate Increases Quarterly Cash Dividend From $0.05 To $0.07 Per Common Share investment picks
SANTA MONICA, Calif., and HELSINKI, July 23, 2014 /PRNewswire/ -- As part of its recently-announced move into the gaming space, Lionsgate (NYSE: LGF) , a premier next generation global content leader, has formed a strategic partnership with the Finnish games developer Next Games and will make an investment in their extended Series A financing round, the two companies announced today.
Sign-up for Lionsgate Partners with Finnish Game Developer Next Games investment picks
LIONSGATE RELOCATES INTERNATIONAL SALES OPERATIONS TO LONDON Move Reflects Globalization of the Company's Business and Positions Lionsgate Closer to Key International Markets Canada NewsWire SANTA MONICA, Calif.
Sign-up for LIONSGATE RELOCATES INTERNATIONAL SALES OPERATIONS TO LONDON investment picks
Move Reflects Globalization of the Company's Business and Positions Lionsgate Closer to Key International Markets SANTA MONICA, Calif.
Sign-up for LIONSGATE RELOCATES INTERNATIONAL SALES OPERATIONS TO LONDON investment picks
Adjusted EBITDA Increases 27% to $77.3 Million Adjusted Basic Net Income per Share Doubles to $0.36 $159.8 Million in Free Cash Flow Delivered in the Quarter SANTA MONICA, Calif.
Sign-up for LIONSGATE REPORTS RESULTS FOR FIRST QUARTER 2015 investment picks
NEW ORLEANS, July 11, 2014 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C.
Sign-up for LIONSGATE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Lions Gate Entertainment Corp. - LGF investment picks
LIONSGATE TEAMS WITH STEPHENIE MEYER, FACEBOOK AND WOMEN IN FILM TO CREATE SHORT FILMS COMPETITION BASED ON CHARACTERS FROM THE WORLD OF TWILIGHT Canada NewsWire Winning Short Films by Aspiring Female Filmmakers to be Chosen By Star-Studded Award-Winning Female Panelists Shorts will Premiere Exclusively on Facebook Next Year VANCOUVER, British Columbia and SANTA MONICA, Calif.
Sign-up for LIONSGATE TEAMS WITH STEPHENIE MEYER, FACEBOOK AND WOMEN IN FILM TO CREATE SHORT FILMS COMPETITION BASED ON CHARACTERS FROM THE WORLD OF TWILIGHT investment picks
Winning Short Films by Aspiring Female Filmmakers to be Chosen By Star-Studded Award-Winning Female Panelists Shorts will Premiere Exclusively on Facebook Next Year VANCOUVER, British Columbia and SANTA MONICA, Calif.
Sign-up for LIONSGATE TEAMS WITH STEPHENIE MEYER, FACEBOOK AND WOMEN IN FILM TO CREATE SHORT FILMS COMPETITION BASED ON CHARACTERS FROM THE WORLD OF TWILIGHT investment picks
Adds Summit Label Titles, Including Allegiant Part 2, to its Slate LONDON and SANTA MONICA, Calif.
Sign-up for Lionsgate UK Expands Distribution Operations investment picks
Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of LipoScience, Inc. (Nasdaq: LPDX) breached their fiduciary duties in connection with the proposed sale of the Company to Laboratory Corporation of America Holdings (LabCorp). Additional Information: LipoScience is engaged in the field of personalized diagnostics based on nuclear magnetic resonance (NMR) technology in the United States.
Sign-up for LIPO SCIENCE SHAREHOLDER ALERT: Proposed Sale of LipoScience, Inc. under Investigation by Johnson & Weaver, LLP in Connection with the Proposed Sale of the Company to Laboratory Corporation of America Holdings investment picks
SALT LAKE CITY, June 30, 2014 (GLOBE NEWSWIRE) -- Lipocine Inc. (Nasdaq:LPCN) , a specialty pharmaceutical company, today announced that it was added to the Russell Microcap Index when Russell Investments reconstituted its comprehensive set of U.S. and global equity indices on June 27, 2014.
Sign-up for Lipocine Added to Russell Microcap Index investment picks
SALT LAKE CITY, Aug.
Sign-up for Lipocine Announces Financial and Operational Results for the Second Quarter of 2014 investment picks
SALT LAKE CITY, July 15, 2014 (GLOBE NEWSWIRE) -- Lipocine Inc. (Nasdaq:LPCN) , a specialty pharmaceutical company, today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent number 8,778,922, entitled "Steroidal Compositions." This patent relates to pharmaceutical compositions having testosterone undecanoate.
Sign-up for Lipocine Announces Issuance of U.S. Patent for LPCN 1021 investment picks
Met primary efficacy endpoint by successfully restoring testosterone levels to the normal range in 88% of the subjects Lower limit of the 95% confidence interval was 82% 85% of the subjects reached final dose with no more than one dose titration Majority of subjects ended on 225 mg BID Proportion of subjects with maximum serum concentrations generally met FDA pre-specified targets LPCN 1021 treatment was well tolerated with no drug related serious adverse events SALT LAKE CITY, Sept.
Sign-up for Lipocine Announces Positive Top-Line Results in Its Phase 3 Study of LPCN 1021 for Oral Testosterone Replacement Therapy investment picks
Achieves Second Quarter Revenue Guidance Healthcore Study Provides Compelling Data on Reduction in Cardiovascular Disease Risk and Events RALEIGH, N.C., Aug.
Sign-up for LipoScience Announces 2014 Second Quarter Financial Results investment picks
2014/9/25
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of LipoScience, Inc. (“LipoScience”) (NasdaqGM: LPDX) concerning the buyout by Laboratory Corp of America Holdings (“LabCorp”). Under the terms of the agreement, valued at approximately $85.3 million, LipoScience shareholders will only receive $5.25 in cash per share owned.
Sign-up for LIPOSCIENCE SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Laboratory Corporation of America investment picks
Shares of LipoScience (LPDX) soared 62% in premarket trade Thursday after the developer of diagnostic tests agreed to be acquired by Laboratory Corp.
Sign-up for LipoScience shares soar after LabCorp's buyout deal investment picks
RALEIGH, N.C., Aug.
Sign-up for LipoScience to Release Second Quarter 2014 Financial Results investment picks
2014/9/25
Rigrodsky & Long, P.A.: Do you own shares of LipoScience, Inc. (NASDAQ GM: LPDX )? Did you purchase any of your shares prior to September 25, 2014?
Sign-up for LIPOSCIENCE, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout investment picks
2014/9/29
WILMINGTON, Del.
Sign-up for LIPOSCIENCE, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout investment picks
2014/9/29
NEW YORK , Sept.
Sign-up for LipoScience, Inc. Stockholders Encouraged to Contact Securities Law Firm about Takeover investment picks
2014/7/16
Acquisition Expected to Expand LiqTech's Ability to Enhance Silicon Carbide Membrane Market Penetration for Water Treatment BALLERUP, Denmark , July 16, 2014 /PRNewswire/ -- LiqTech International, Inc. (NYSE MKT: LIQT) ("LiqTech") announces today that it has signed a definitive agreement to acquire the operations of Provital Solutions A/S ("Provital Solutions" or "Provital"), a Denmark -based water solutions company specialising in integrated filtration solutions for the swimming pool and spa market segments.
Sign-up for LiqTech Announces Agreement To Acquire Operations Of Provital Solutions investment picks
2014/9/10
BALLERUP, Denmark , Sept.
Sign-up for LiqTech International Inc. to Present at Craig-Hallum Capital Group 5th Annual Alpha Select Conference investment picks
2014/7/24
- Management to Conduct Conference Call on Tuesday, July 29th at 11am ET - BALLERUP, Denmark , July 24, 2014 /PRNewswire/ -- LiqTech International Inc., (NYSE MKT: LIQT), a clean technology company that manufactures and markets highly specialized filtration technologies, today announced that it will conduct a conference call on July 29th at 11am ET to discuss the recent stock offering and LiqTech's announcement that it has reached an agreement to acquire Provital Solutions A/S, a Denmark -based water solutions company specializing in integrated filtration solutions for the swimming pool and spa market segments.
Sign-up for LiqTech International to Discuss Recent Stock Offering and Agreement to Acquire Provital Solutions investment picks
2014/8/6
- Management to Conduct Conference Call on Tuesday, August 12th at 11am ET - BALLERUP, Denmark , Aug.
Sign-up for LiqTech International to Report Second Quarter Financial Results investment picks
2014/7/31
-Order Placed by Danish Fish Farm to Filter Sea Water for Recirculated Aquaculture System- BALLERUP, Denmark , July 31, 2014 /PRNewswire/ -- LiqTech International, Inc. (NYSE MKT: LIQT) ("LiqTech") is pleased to announce that the Company received a $350,000 Silicon Carbide (SiC) membrane system order from a Danish customer to be delivered this year.
Sign-up for LiqTech International, Inc. Announces $350,000 First Order Received By The Newly Combined LiqTech/Provital Company investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Lionsgate Increases Quarterly Cash Dividend From $0.05 To $0.07 Per Common Share to LiqTech International, Inc. Announces $350,000 First Order Received By The Newly Combined LiqTech/Provital Company
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices